Home » Immuno-oncology

We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Register on R&D Systems

Immuno-oncology

Unlocking the Potential of Biosimilars in Immuno-Oncology

Purple and blue antibodies with clear glass vial in the middle on a purple-blue background.

By Jennifer Jones, M.S.

Tags: 
Biosimilar
Biosimilar Antibody
Cancer
Cancer Immunotherapy
Immuno-oncology
Adalimumab
Atezolizumab
Bevacizumab
Nivolumab
Pembrolizumab
rituximab
trastuzumab
CD20
CD30/TNFRSF8
CD52
CTLA-4
ErbB2/Her2
PD-1
PD-L1
TNF-alpha
VEGF
Jennifer Jones

Synthetic Biotic Medicine as Immunotherapy Against Cancer: Evidence From Arginine-Producing Engineered Bacteria

3D banner image showing example of pathogenic bacteria.

By Jamshed Arslan, Pharm D, PhD

Tags: 
Bacteria
Cancer
Cancer Research
Checkpoint Blockade
Checkpoint Inhibitors
immunology
Immuno-oncology
Immunotherapy
Innate Immunity
L-arginine
T Cells
Tumor
ARG-2
CD4
CD8
PD-1
PD-L1
Jamshed Arslan

Harnessing Natural Killer Cell Activity for Anti-Tumor Immunotherapy

Banner image showing the workflow for Natural Killer (NK) cells.

By Victoria Osinski, PhD

Tags: 
Natural Killer Cell
NK Cell
Cancer
immunology
Immuno-oncology
Immunotherapy
CD8
MHC Class I
NKG2A/CD159a/KLRC1
NKG2C/CD159c/KLRC2
NKG2D/CD314
NKG2E/KLRC3
KLRC4
NKG2H
DAP12
Killer Cell Immunoglobulin-like Receptor
CD7
CD19
Siglec-3/CD33
MUC1
ErbB2/Her2
MICA
MICB
ULBP
HDAC
HLA G
KIR2DL4/CD158d
Victoria Osinski

Advancing CAR T Therapies with CRISPR/Cas9

Expression of CD4 and CD8 in peripheral blood mononuclear cells ICC

By Victoria Osinski

Tags: 
CRISPR-Cas9
Lymphocytes
T Cells
Tumor
Cancer
Cancer Research
CAR-T
Immunotherapy
Immuno-oncology
immunology
CRISPR/Cas9